CD4 and neoplasm: Reports have showcased clear tumor inhibition following pFUS in 4T1 tumors (68, 72), where exposures were reported to increase CD4+ T cells, CD8+ T cells, DCs (68, 72), and NK cells (72) within tumors (63).